国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

USEUROPEAFRICAASIA 中文雙語Fran?ais
Lifestyle
Home / Lifestyle / Health

China's potent answer to Viagra

By Liu Zhihua | China Daily | Updated: 2014-09-26 07:04

China's potent answer to Viagra
Angelina Jolie surgery sparks surge in female cancer tests: study
China's potent answer to Viagra
Stay smiling
There are no reliable figures for ED's prevalence in China. But US figures show 52 percent of American men older than 40 suffer from the disorder. Guo Yinglu, a Chinese Academy of Engineering member and one of the country's leading urological surgeons, believes the Chinese figure is about the same.

Zhang Buyong, a principal researcher with the SFDA's South Medicine Economy Research Institute, estimates more than 120 million Chinese men have ED. "That would mean an ED treatment market of 1.3 billion yuan ($211 million) in China, with a rapid annual increase," Zhang says.

Foreign manufacturers currently dominate the market.

Viagra's producer Pfizer controls nearly half the market, followed by Cialis' producer Eli Lilly and Co, and Levitra's producer Bayer AG. Viagra is very expensive - more than 100 yuan a pill, Zhang says.

Guangzhou Baiyunshan is the first Chinese company to receive SFDA approval to produce the ED medicine.

The company started research and development on ED medicine that uses sildenafil as the main ingredient in the 1990s but had to halt its research after Viagra was patented in China in 2001, explains Li Chuyuan, president of Guangzhou Baiyunshan's parent company Guangzhou Pharmaceutical Holdings.

Guangzhou Baiyunshan is first past the post among the Chinese companies vying to produce the medicine because of its track record, Li says. Also, it employed the services of Ferid Murad, the co-winner of the Noble Prize in Physiology or Medicine in 1998, whose work on nitric oxide led to Viagra's development.

Guangzhou Baiyunshan will change the status quo of China's ED medicine market because it has the advantages of lower pricing and more sales channels than foreign rivals, Zhang Buyong says.

At the news conference, Guangzhou Baiyunshan signed agreements with leading pharmacy chains to distribute Jin'ge and says it's confident it can meet the vast demand because it can produce 4 billion pills a year.

Previous 1 2 Next

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
谢通门县| 天台县| 曲松县| 左贡县| 沙雅县| 石屏县| 沙坪坝区| 美姑县| 白朗县| 封开县| 长垣县| 本溪市| 泾阳县| 邵阳市| 鄂托克前旗| 七台河市| 新闻| 若尔盖县| 十堰市| 汪清县| 察雅县| 漳浦县| 曲麻莱县| 东莞市| 赞皇县| 天等县| 临猗县| 云安县| 丰宁| 余江县| 鹤庆县| 张家港市| 轮台县| 都昌县| 平利县| 康平县| 怀化市| 西乡县| 崇明县| 淅川县| 施秉县|